Development and Evaluation of Microemulsions for Transdermal Delivery of Insulin

<table><i>In vitro</i> insulin permeation profile through goat skin per unit area from selected insulin-loaded microemulsions (F3 and F6) without and with 2% DMSO as permeation enhancer (F7 and F8). (mean ± standard error, <svg height="10.9125" id="M33" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 35.099998 10.9125" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.9125)">
<g transform="translate(72,-63.27)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">3</tspan>
</text>
</g>
</g>
</svg>).</table>

International Scholarly Research Notices

fig3

Figure 3

Figure 3: Development and Evaluation of Microemulsions for Transdermal Delivery of Insulin 